Nice to know we have someone who already knows the outcome of the trials.
5 billion shares not that unusual for a startup stock. Yes there will be a likely consolation coming but again not unusual. Spare me the horrid consolation drama, again not uncommon, if you have bought and not factored one in then it’s something that needs thought.
Without further expansion from you on the many reasons why this will never fly we can only assume the following. 1/ The trials prove IVX-P02 is ineffective in animal trials, product is back to the lab or dead in the water. 2/ The trials prove IVX-P02 effective in animal trials, product moves to human trials and proves ineffective, product back to the lab or dead in the water. 3/ The trials prove IVX-P02 effective in animal trails, product moves to human trails and proven effective at killing cancer cells in humans, Phase 1,2,3 trials proven effective at killing cancer in humans....Nobody cares and product in not approved for use.
The way I see it only two of the above three are a possibility.
IVX Price at posting:
1.6¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)